Sera Prognostics, based in Salt Lake City, UT, is developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. Specifically, Sera Prognostics currently has a novel preterm birth risk prognostic on the market, the PreTRMTM test, the first blood-based diagnostic of its kind whose performance in assessing preterm birth risk exceeds any test currently used. The foundation is working with Sera to develop their technology as affordable and accessible tests to help women and infants in the developing world.
Investment Date: January 2015